<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore risk factors for <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> treated in primary care </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A prospective population-based study of 400 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> who consecutively completed an annual checkup in primary care in Skara, Sweden, during 1992-1993 </plain></SENT>
<SENT sid="2" pm="."><plain>Vital status was ascertained to year 2000 </plain></SENT>
<SENT sid="3" pm="."><plain>Baseline characteristics as predictors for mortality were analyzed by Cox regression and expressed as relative risks (RRs), with 95% CIs </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: During a mean follow-up time of 5.9 years, 131 patients died (56 <z:hpo ids='HP_0011420'>deaths</z:hpo> per 1,000 patients per year) </plain></SENT>
<SENT sid="5" pm="."><plain>In both sexes, <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality was predicted by HbA(1c) (by 1%; RR 1.14, 95% CI 1.01-1.27), and by <z:chebi fb="15" ids="39026">LDL</z:chebi>-to-<z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi> ratios (1.15, 1.00-1.32) </plain></SENT>
<SENT sid="6" pm="."><plain>Increased mortality was also seen with prevalent <z:hpo ids='HP_0000822'>hypertension</z:hpo> (1.72, 1.21-2.44), <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (1.87, 1.27-2.76), and previous <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (1.70, 1.15-2.50) </plain></SENT>
<SENT sid="7" pm="."><plain>Subanalyses revealed that increased mortality related to HbA(1c) was restricted to hypertensive patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (1.23, 1.04-1.47) </plain></SENT>
<SENT sid="8" pm="."><plain>Serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (by 1 mmol/l) predicted <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality in women (1.25, 1.06-1.47) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Poor <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> control and <z:hpo ids='HP_0000822'>hypertension</z:hpo> predicted <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
<SENT sid="10" pm="."><plain>Survival was also predicted by prevalent <z:mp ids='MP_0002959'>microalbuminuria</z:mp> and by previous <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Confirming results from clinical trials, this population-based study has implications for primary and secondary prevention </plain></SENT>
</text></document>